Home » AstraZeneca COVID-19 Vaccine

AstraZeneca COVID-19 Vaccine

U.S. pledges sustained help for India in tackling coronavirus crisis

Senior U.S. officials on Tuesday pledged sustained support for India in helping it deal with the world’s worst current surge of COVID-19 infections, warning the country is still at the “front end” of the crisis and overcoming it will take some time. The White House’s National Security Council coordinator for the Indo-Pacific, Kurt Campbell, told a virtual event on the U.S. assistance that President Joe Biden had told Indian Prime Minister Narendra Modi on a phone call on Monday: “You let me know what you need and we will do it.” Campbell said at the event, organized by the U.S.-India Business Council and U.S. Chamber of Commerce Foundation, that Washington was committed to helping the world’s second most populous country get to grips with the crisis. “We all have to realize that this is no...

Only 49% of South Africans will take the COVID-19 Vaccine, Research Shows

Although COVID-19 infection rates seem to be declining and vaccines are slowly being rolled out in the country, most South Africans are wary of a third wave, further lockdowns and job losses. A survey by gig technology company, M4Jam asked South Africans about their main concerns as the country marked exactly one year since the first COVID-19 case in the country was diagnosed. Despite South Africa’s rejection of its first shipment of vaccines and widespread misinformation about the effectiveness of vaccinations, 49% of respondents (up from 32% in the January survey) said they would take the vaccine when it became available to them. 44% of respondents (down from 58% in the January survey) said they would adopt the approach of “wait and see” if the vaccine works for people they knew before m...

AstraZeneca Promises 2 Million Additional COVID-19 Vaccines to Ghana

Image sourced from TimesLIVE Ghana is expected to receive an additional two million AstraZeneca COVID-19 vaccines by the end of May, on top of the already promised 600,000 COVID-19 vaccines from Covax – this would aid the country’s mission to vaccinate around 20 million Ghanaians. According to News Ghana, more than 300,000 people have been vaccinated since the COVID-19 mass vaccination programme started on 2 March 2021. “Those who received doses of the AstraZeneca vaccines included, health care workers, persons with underlying health conditions, essential service providers and those who were 60 years and above, as well as members of the security agencies, Executive, Legislature and Judiciary branches of government.” /* custom css */ .tdi_3_abe.td-a-rec-img{ text-align: left; }.tdi_3_abe.td...

Nigerian government coronavirus vaccine has mild side effect

The Minister of Health, Osagie Ehanire, has pointed out that the AstraZeneca COVID-19 vaccine has a mild side effect. Ehanire explained that those vaccinated may experience “small pain” in the area it was injected. He disclosed this after the vaccination of President Muhammadu Buhari and his Vice, Yemi Osinbajo, at the State House, yesterday. Ehanire, however, stated that the administration of the COVID-19 vaccine is expected to be painless. He said: “The process itself is simple. We are using a narrow gauge syringe, which will be very painless, and it is a small quantity that is injected into the muscle of your upper arm. “The after-effects, as we know so far, are mild. There can be a small pain in the area where it was injected.” Meanwhile, Buhari after receiving the vaccine, had urged N...

AstraZeneca Vaccine Only ‘Minimally Effective’ Against South African COVID-19 Variant, says Researchers

Image sourced from TimesLIVE The AstraZeneca COVID-19 vaccine has proven ‘minimally effective’ against the South African variant, according to the Wits Vaccines and Infectious Diseases Analytics (VIDA) research unit. So far, South Africa has received one million doses of the Oxford/AstraZeneca vaccine. In an official report, researchers from South Africa and the UK found that “viral neutralisation by sera induced by the ChAdOx1 nCoV-19 coronavirus vaccine against the B.1.351 coronavirus variant were substantially reduced when compared with the ‘original’ strain of the coronavirus”. /* custom css */ .tdi_3_ec0.td-a-rec-img{ text-align: left; }.tdi_3_ec0.td-a-rec-img img{ margin: 0 auto 0 0; } Professor of Vaccinology at the University of Oxford, Sarah Gilbert revealed that efforts are alrea...